I work with the companies building the future of point-of-care ultrasound — and the investors and health systems betting on it.

For the last decade I've practiced emergency medicine, run academic and community ED ultrasound programs, reviewed thousands of clinical scans, and built ultrasound divisions from the ground up. That vantage point — what works at the bedside, what fails in real workflows, what clinicians will and won't adopt — is what I bring to the teams shaping where POCUS goes next.

I'm selective about engagements. I take on a small number of advisory relationships at a time so the work is substantive, not symbolic.

Who I work with

POCUS device, AI, and software companies.

Early- and mid-stage teams building hardware, AI interpretation, workflow software, or image management. Common engagements: real-world clinical read on product and roadmap, adoption strategy, regulatory clinical input, KOL and medical affairs work, and customer development with the clinicians you're actually selling to.

Healthcare investors.

Diligence support on POCUS, imaging AI, and emergency medicine tech. An operator's read on what's clinically real versus what looks good in a pitch deck — and ongoing advisor placement into portfolio companies.

Health systems and physician groups.

Strategic consulting on POCUS program design, billing capture, credentialing pathways, and QA infrastructure. Most often engaged by hospital executives, PE-backed ED and urgent care groups, and large multi-site practices.

What engagements look like

Clinical and product advisory: typically a retainer with a defined monthly time commitment, usually a mix of cash retainer and equity. Diligence and one-time strategic engagements: scoped projects, typically 2–8 weeks, project-based pricing. Health system and program engagements: scoped over 3–6 months for activation work, with optional ongoing QA partnerships.

What I don't do

I'm not a generic medical KOL. I don't lend my name to products I haven't used or evaluated. I don't take on engagements where the ask is to validate a thesis the company has already decided on. I don't do white-label content production. And I don't take on more than a small number of advisory roles at any given time, because doing so would compromise the quality of attention I can bring to each.

Get in touch

If you're building or investing in something in this space, I'd like to hear about it. The fastest path is a short note describing what you're working on, what stage you're at, and what you're hoping I can help with.